Antibiotic preparations relating to doxorubicin; chemotherapeutics relating to doxorubicin; pharmaceutical preparations for the treatment of tumours relating to doxorubicin; pharmaceutical preparations for chemical disorder treatment relating to doxorubicin; pharmaceutical agents affecting sensory organs relating to doxorubicin; pharmaceutical agents affecting metabolism relating to doxorubicin; pharmaceutical agents affecting peripheral nervous system relating to doxorubicin; cardiovascular ...